SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-014582
Filing Date
2020-12-31
Accepted
2020-12-31 07:06:35
Documents
16
Period of Report
2020-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20201231x8k.htm   iXBRL 8-K 46355
2 EX-99.1 axsm-20201231xex99d1.htm EX-99.1 28492
3 EX-99.2 axsm-20201231xex99d2.htm EX-99.2 26805
4 GRAPHIC axsm-20201231xex99d1001.jpg GRAPHIC 4928
5 GRAPHIC axsm-20201231xex99d2001.jpg GRAPHIC 4928
  Complete submission text file 0001558370-20-014582.txt   254363

Data Files

Seq Description Document Type Size
6 EX-101.SCH axsm-20201231.xsd EX-101.SCH 3252
7 EX-101.LAB axsm-20201231_lab.xml EX-101.LAB 16161
8 EX-101.PRE axsm-20201231_pre.xml EX-101.PRE 10967
9 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20201231x8k_htm.xml XML 4917
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 201427482
SIC: 2834 Pharmaceutical Preparations